Literature DB >> 17044467

Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand.

Suraphan Panomsak1, Songkiat Lewsuwan, Somchai Eiam-Ong, Talerngsak Kanjanabuch.   

Abstract

Hepatitis B virus (HBV)-associated glomerulonephropathy (HBV-GN) has been increasingly reported, especially in adults. In the present study, the authors investigated the clinical and histopathology features of patients who suspected HBV-GN in 24 patients and age ranging from 23 to 74 years (mean 43 years). Asymptomatic hematuria was the most common presentation (54%); followed by edema and hypertension at equal percentages of 50%. The nephrotic syndrome was presented in 43%, the nephrito-nephrotic syndrome in 3.5%. Clinically suspected rapidly progressive GN was found in 14%. Renal insufficiency was determined in 30%. The most common pathologic finding was IgA nephropathy (IgAN 29%), followed by membranous nephropathy (21%), focal segmental glomerulo sclerosis (FSGS 11%), membranoproliferative GN (11%), post-infectious GN (11%). Liver disease activity also tended to be mild or had no symptoms of hepatitis. The authors remission rates both complete and partial were 75% (higher than the usual report), notwithstanding treatment. The authors achieved a sustained complete remission in half of the patients (3 in 6 cases) treated with steroid alone and 2 out of 7 cases (28.6%) treated with anti-viral therapy. Spontaneous remission was demonstrated in 2 (1 with IgAN + FSGS, and 1 with post infectious GN) out of 6 patients (33.3%). None of the patients in both treatment groups turned to ESRD that occurred in 2 cases receiving non-specific treatment. Of note, all of the patients who received anti-viral therapy or corticosteroid and had complete follow up were in remission either complete or partial.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044467

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  7 in total

Review 1.  Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.

Authors:  Xiao-Yong Zheng; Ri-Bao Wei; Li Tang; Ping Li; Xiao-Dong Zheng
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

2.  Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.

Authors:  Yu Zhang; Jian-Hua Zhou; Xiao-Ling Yin; Feng-Yu Wang
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 3.  [Diagnostics of glomerulonephritis].

Authors:  S M Weiner; R Waldherr; J Kriegsmann
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

4.  The relationship between HBV serum markers and the clinicopathological characteristics of hepatitis B virus-associated glomerulonephritis (HBV-GN) in the northeastern chinese population.

Authors:  Lei Zhang; Hongxue Meng; Xingying Han; Changsong Han; Chuanhui Sun; Fei Ye; Xiaoming Jin
Journal:  Virol J       Date:  2012-09-14       Impact factor: 4.099

5.  Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.

Authors:  Baohui Fu; Yue Ji; Shouci Hu; Tong Ren; Maheshkumar Satishkumar Bhuva; Ge Li; Hongtao Yang
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

6.  Clinical and histopathological analyses of kidney biopsies in a single center for 7 years.

Authors:  Seunghye Lee; Sehyun Jung; Mi-Ji Kim; Jong Sil Lee; Ha Nee Jang; Se-Ho Chang; Hyun-Jung Kim
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

Review 7.  Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature.

Authors:  Ambar Khaira; Bala Krishna Upadhyay; Alok Sharma; Prasenjit Das; Sandeep Mahajan; Govind Makhariya; Amit K Dinda; Sanjay K Agarwal; Suresh C Tiwari
Journal:  Clin Exp Nephrol       Date:  2009-01-24       Impact factor: 2.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.